C. J. Watson

5.4k total citations
101 papers, 2.0k citations indexed

About

C. J. Watson is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. J. Watson has authored 101 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 50 papers in Pediatrics, Perinatology and Child Health and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. J. Watson's work include Porphyrin Metabolism and Disorders (71 papers), Neonatal Health and Biochemistry (50 papers) and Heme Oxygenase-1 and Carbon Monoxide (40 papers). C. J. Watson is often cited by papers focused on Porphyrin Metabolism and Disorders (71 papers), Neonatal Health and Biochemistry (50 papers) and Heme Oxygenase-1 and Carbon Monoxide (40 papers). C. J. Watson collaborates with scholars based in United States, United Kingdom and China. C. J. Watson's co-authors include Ruth Cardinal, Irene Bossenmaier, Z. J. Petryka, Violet Hawkinson, M. Weimer, Luigi Taddeini, Ken Miyagi, Samuel Schwartz, Gaurav Dhar and Claus A. Pierach and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

C. J. Watson

100 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. J. Watson United States 27 1.6k 853 405 245 121 101 2.0k
Beverly W. Gabrio United States 25 624 0.4× 406 0.5× 103 0.3× 92 0.4× 17 0.1× 34 1.6k
Arlene R. Cashmore United States 22 721 0.5× 56 0.1× 103 0.3× 312 1.3× 48 0.4× 35 1.3k
J A Belt United States 18 739 0.5× 288 0.3× 83 0.2× 30 0.1× 30 0.2× 28 1.8k
Claude F. Reed United States 14 622 0.4× 227 0.3× 250 0.6× 15 0.1× 17 0.1× 18 1.6k
N. F. Maclagan United Kingdom 19 360 0.2× 52 0.1× 98 0.2× 55 0.2× 35 0.3× 66 1.2k
Javier G. Blanco United States 24 600 0.4× 420 0.5× 158 0.4× 23 0.1× 25 0.2× 75 1.8k
E Schneider United States 17 1.0k 0.6× 253 0.3× 58 0.1× 46 0.2× 32 0.3× 21 1.8k
Nicola Tavoloni United States 23 474 0.3× 224 0.3× 107 0.3× 26 0.1× 18 0.1× 59 1.8k
J F Riordan United Kingdom 17 753 0.5× 48 0.1× 140 0.3× 16 0.1× 91 0.8× 31 1.5k
Douglas W. Loe Canada 14 917 0.6× 1.1k 1.3× 96 0.2× 52 0.2× 12 0.1× 14 3.0k

Countries citing papers authored by C. J. Watson

Since Specialization
Citations

This map shows the geographic impact of C. J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. J. Watson more than expected).

Fields of papers citing papers by C. J. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. J. Watson. The network helps show where C. J. Watson may publish in the future.

Co-authorship network of co-authors of C. J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of C. J. Watson. A scholar is included among the top collaborators of C. J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. J. Watson. C. J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petryka, Z. J. & C. J. Watson. (1979). Separation and spectrodensitometric quantitation of porphyrin esters on thin-layer chromatograms. Journal of Chromatography A. 179(1). 143–149. 19 indexed citations
2.
Pierach, Claus A., Ruth Cardinal, Irene Bossenmaier, & C. J. Watson. (1977). Comparison of the Hoesch and the Watson-Schwartz tests for urinary porphobilinogen.. Clinical Chemistry. 23(9). 1666–1668. 24 indexed citations
3.
Pierach, Claus A., et al.. (1977). Effect and fate of intravenously administered porphobilin in rats. Cellular and Molecular Life Sciences. 33(7). 873–874. 3 indexed citations
4.
Miyagi, Ken, Z. J. Petryka, Irene Bossenmaier, Ruth Cardinal, & C. J. Watson. (1976). The activities of uroporphyrinogen synthetase and cosynthetase in congenital erythropoietic porphyria (cep). American Journal of Hematology. 1(1). 3–21. 23 indexed citations
5.
Watson, C. J.. (1973). Lack of Significant Effect of Vitamin E on Porphyrin Metabolism. Archives of Internal Medicine. 131(5). 698–698. 10 indexed citations
7.
Miyagi, Ken, Ruth Cardinal, Irene Bossenmaier, & C. J. Watson. (1971). The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.. PubMed. 78(5). 683–95. 78 indexed citations
8.
Petryka, Z. J. & C. J. Watson. (1968). Separation of bile pigments by thin layer chromatography. Journal of Chromatography A. 37(1). 76–82. 18 indexed citations
9.
Watson, C. J.. (1968). Griseofulvin and porphyrin metabolism.Special reference to normal fecal porphyrin excretion. Archives of Dermatology. 98(5). 451–468. 5 indexed citations
10.
Watson, C. J.. (1967). Linacre and Locke:pillars of medical humanism.. PubMed Central. 107(5). 20–29. 1 indexed citations
11.
Watson, C. J., et al.. (1966). The Isolation of Crystalline i-Urobilinogen (Mesobilirubinogen) from Feces. Journal of Biological Chemistry. 241(21). 5037–5043. 9 indexed citations
12.
Watson, C. J.. (1966). Pursuit of the Purple. JAMA. 197(13). 1074–1074. 10 indexed citations
13.
Watson, C. J., et al.. (1964). A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND III PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA. Proceedings of the National Academy of Sciences. 52(2). 478–485. 48 indexed citations
14.
Watson, C. J.. (1963). Recent studies of the urobilin problem. Journal of Clinical Pathology. 16(1). 1–11. 28 indexed citations
15.
Taddeini, Luigi, I. T. Kay, & C. J. Watson. (1962). Inhibition of the Ehrlich's reaction of porphobilinogen by indican and related compounds. Clinica Chimica Acta. 7(6). 890–891. 7 indexed citations
16.
Runge, Walter & C. J. Watson. (1962). Experimental Production of Skin Lesions in Human Cutaneous Porphyria.. Experimental Biology and Medicine. 109(4). 809–811. 19 indexed citations
17.
Watson, C. J., et al.. (1962). STUDIES OF THE DIPYRRYLMETHENE (“FUSCIN”) PIGMENTS. III. THE VARIABLE FATE OF BILIRUBIN DEPENDING UPON CONJUGATION AND OTHER FACTORS*. Journal of Clinical Investigation. 41(5). 1041–1049. 4 indexed citations
18.
Watson, C. J.. (1959). Some Studies of the Comparative Biology of Human and Bovine Erythropoietic Porphyria. Archives of Internal Medicine. 103(3). 436–436. 27 indexed citations
19.
Watson, C. J., Richard L. Varco, & R. Schmid. (1957). An unusual case of acute porphyria with volvulus and gangrene of the cecum. The American Journal of Medicine. 22(6). 980–985. 3 indexed citations
20.
Watson, C. J.. (1953). THE DIRECT PREPARATION OF CRYSTALLINE UROBILIN FROM BILIRUBIN. Journal of Biological Chemistry. 200(2). 691–696. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026